HOME >> MEDICINE >> NEWS
Studies suggest investigational agent reduces disease activity in MS

BOSTON A new drug under investigation shows a reduction in disease activity in multiple sclerosis (MS), according to two studies that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston, April 28 May 5, 2007. The drug reduced disease activity as indicated by MRI scans.

Both of the studies involved people with the relapsing-remitting form of MS, where symptoms flare up and then subside. By 24 weeks, treatment with the drug rituximab reduced the number of areas of brain damage, or lesions, in people with MS and the number of relapses, or times when symptoms flare up, when compared with placebo.

Rituximab is a therapeutic antibody that selectively targets and depletes a subset of immune cells called B-cells by targeting a specific protein on their surface.

"This is the first drug to target B-cells and may represent a potential new treatment strategy for relapsing-remitting MS," said study author Stephen Hauser, MD, of the University of California, San Francisco, and a member of the American Academy of Neurology. "While these are early stage clinical trials, these results are exciting, because the current drugs available for MS are only partially effective in reducing disease activity and preventing exacerbations. New and more effective treatments for MS are sorely needed, especially for people who do not adequately respond to currently available medications. These data are also important because they demonstrate that B-cells, which are the precursors of antibody-producing cells, play an essential role in mediating relapses of MS."

In the first study, a randomized, placebo-controlled trial, 69 people were given two infusions of rituximab two weeks apart and 35 were given a placebo. The participants were followed for six months. Those given rituximab had approximately 90 percent fewer brain lesions than those given placebo. During the six-month period, 58 percent fewer of those taking the d
'"/>

Contact: Angela Babb
ababb@aan.com
651-695-2789
American Academy of Neurology
1-May-2007


Page: 1 2 3

Related medicine news :

1. Studies show antidepressants not linked to birth defects
2. Studies show role of age, gender, race and weight on cancer risk and treatment
3. Studies highlight advances in diagnosis, medical therapy
4. Studies highlight real world use, safety of drug-eluting stents
5. Studies led by Rhode Island Hospital confirm safety and efficacy
6. Studies identify food sources of disease and drug resistance
7. Studies provide new evidence on risks associated with Cox-2 inhibitors and NSAIDs
8. Studies highlight need to monitor heart function in breast cancer patients
9. Studies examine physician disclosure of medical errors
10. Studies indicate medication can be an effective therapy for smoking cessation
11. Studies evaluating health effects of dental amalgam fillings in children confirm safety

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2018)... ... August 07, 2018 , ... The American ... selected to receive the 2018 Board of Directors Student Scholarship . The ... of psychiatric-mental health nursing and develop the next generation of leaders in the ...
(Date:8/3/2018)... ... 2018 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... the Bible meant only to be understood in this current generation. Yisrayl says he ... decode passages that he says scholars have struggled with for generations. Yisrayl says the ...
(Date:8/2/2018)... Pa. (PRWEB) , ... August 02, 2018 , ... ... lifeIMAGE medical image e-sharing platform to connect clinicians inside and outside ... patients suffering a life-threatening stroke or trauma. , AHN joins other leading hospital ...
(Date:8/2/2018)... Conn. (PRWEB) , ... August 02, 2018 , ... ... (TGA) to its prestigious Top 20 Training Delivery Companies of 2018 . ... “Our mission is to empower training industry professionals with the game-based tools they ...
(Date:8/2/2018)... ... August 01, 2018 , ... Primary care practices in Rochester, ... makes actionable recommendations for victims and their doctors. , A team of researchers ... (RESOLVE) developed the software program. , “Family care practitioners are often the ...
Breaking Medicine News(10 mins):
(Date:8/15/2018)... ... 15, 2018 , ... During a special ceremony at the ... Illinois, was named the grand prize winner of the 2018 IsaBody Challenge®. The ... a global health and wellness company providing nutrition and lifestyle solutions. , ...
(Date:8/14/2018)... ... August 14, 2018 , ... ... commitment of more than $270,000 to expand a popular pet therapy program. ... full-time coordinator to facilitate more visits to patients throughout the hospital and outpatient ...
(Date:8/11/2018)... ... August 10, 2018 , ... Last month, Dr. Tim Herman, ... to deliver dental care in underserved communities surrounding its capital of Asunción. Along with ... Dr. Herman volunteered his time to help deliver care to over 550 individuals in ...
Breaking Medicine Technology:
Cached News: